IS Moderna making a vaccine – or is it a hoax?  

Moderna is a relatively new biomedical company formed in September 2009 and going public in 2018 with a valuation estimated to be roughly $7.5 billion and cumulative losses of $1.5 billion.   Since its inception it has never made a profit.

While Moderna has conducted a few trials with large pharma collaboratives including Astra-Zeneca and Alexion, none of those trials have ever been successful.

Moderna moved to lower class vaccine development in 2014 and analysts predicted their demise.   As a result, Rossi, the founding biologist, left the company.

Shifting platforms, Moderna altered their focus and the technology platform instituted was a focus on mRNA Vaccines wherein synthetic mRNA would be inserted into living cells that would reprogram the cells to develop immune responses.  It is a novel technique abandoned by several large pharmaceutical and biotechnology companies due to their inability to overcome the severe side effects associated with the procedure methodology.

As of May 2020, no mRNA drug has been approved for human use. However this is the technique being employed in Moderna’s ‘supposed’ trials for a CoVid vaccine.   The likelihood of fast tracking a methodology that has failed for the past 40 years in trials is seemingly ludicrous – at best.

So what is Moderna really doing?

In 2010, Rossi, the initial creator of Moderna brought in Flagship Pioneering as a co-investor. Flagships CEO, Noubar Afeyan brought in a new Moderna CEO, Stephane Bancel who is known as a well-groomed stock manipulation player.

Moderna claimed to begin making its CoVid vaccine in January 2020 well before the virus was determined to be of pandemic proportions.  Setting the stage as the pre-emptive player, Bancel parlayed some very special sales pitch skills into a lucrative contract with NIAID despite a track record of – nothing but failures.

Since March 2020, key executives have been selling off their shares massively while reaping incredible profits from the CoVid hype according to SEC documents.   In February the stock was selling for around $18 per share, by July it had reached $87 despite having no assets other than cash.

Bancel and key executives have become billionaires in six months.  And yet, their key product fast tracked for delivery is a method that has proven unsuccessful due to severe reactions.

So far, Moderna claims to have conducted successful trials on monkeys and 45 humans – although serious side effects did occur such as delirium, high fever, chills, muscle pain, headaches and nausea – some causing hospitalization, Dr. Lisa Jackson of Kaiser’s Health Research Institute in Seattle (also connected with CDC and NIH), claims that is considered success!

The vaccine deposits the virus directly into a person’s cells with a 3-prong needle which supposedly causes the cells to fight the virus and produce antibodies.   Of the 45 human trials all were young, fit, and healthy – 20% reported ‘severe side effects typical for previous attempts to create an mRNA vaccine for SARS, 80% reported side effects.

Since March, key executives have sold off massive shares of their holdings while the general public is hyped by a delirious trial.

As such the FDA gave permission for Bancel to conduct testing on 30,000 humans in conjunction with NIH. What?

Various lawyers are calling for a criminal investigation.

In a clinical study conducted by NIH in February 2020, mRNA responses could include:

1. Medically adverse effects that could occur after the original singular vaccine for up to a year.
2. New onset chronic diseases that could occur after the vaccine up to a year post.
3. Serious adverse effects that could take a year to show
4. In the event that the virus mutates, mRNA could cause serious events that would be more dangerous than the original virus.

Other pharma companies enlisted in the CoVid vaccine marathon include Astra Zeneca which has also gone on to phase 3 of Trials despite 60% or more of subjects experiencing severe side effects sometimes not until 1 month after the vaccination. While Astra-Zeneca’s vaccine also includes T-cell responses, new studies have shown that antibodies can disappear within 3 weeks and T-cell responses within a few years thus requiring a constant load of boosters.

That means a vaccine will only protect a person for a few weeks… thus Bill Gates has stated that multiple vaccinations will be required per person. Based on the antibody approach that would mean a vaccine once per month? I doubt any trial will utilize this massive regimen in evaluating side effects. Brazil, South Africa, UK and the US are the point target for subject volunteers…

Most of the Pharma companies producing a vaccine will require a no liability clause in the event anyone contracts any debilitating side effects.

Recently, articles abound claiming a Fauci/Gates collaboration thru patents. In 2018 Fauci was granted a patent for a method of contacting a cell, specifically a T-cell, with an effective amount of an agent to reduce infection – specifically HIV. While Fauci and others are deemed the inventors, the assignee is the US Department of Health.  In fact, NIH or the Department of Health hold all the patents invented by their employees.

In 2015, Dr. Jeff Bradstreet was ‘suicided’ for his own discovery of an injectable protein binding substance that occurs naturally in every human – albeit those with immune deficiencies lack this protein – McGAF. He had success in treating cancer, HIV, and other diseases with this protein agent.   The fact that it occurs naturally in the human body made it ‘unpatentable’.   All his work and vials were confiscated by the FDA…

Could Fauci’s patent be a regurgitation of work confiscated from Bradstreet?

According to RFK, Jr., NIAID, of which Fauci is head, will receive 50% royalty rights to any vaccine given the cell factor per the patents.  However, again it should be noted that this methodology has NEVER been used on humans due to it failing clinical trials since 1980!

While Bill Gates does not personally hold any pharma shares, buying and selling thru a vast menagerie of holding companies is more typical and certainly opaque.   It is likely any shares he sold would have been short-term like the Moderna executives.   A fast buck.

However, instead he is busily building the facilities that will produce the vaccines – nine in total. No matter who wins the race, Gates will own the means.

And That’s How It Is Done.